2
Clinical Trials associated with CD19CD22 CAR-T Therapy(The First Affiliated Hospital of Soochow University) / Not yet recruitingPhase 2IIT Safety and Efficacy of CD22/CD19 CAR-T and Blinatumomab Combined With Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-cell Acute Lymphoblastic Leukemia
Chimeric antigen receptor T-cell (CAR-T) therapy has achieved remarkable efficacy in B-cell acute lymphoblastic leukemia (B-ALL). However, relapse after CAR-T has been a major issue. Multi-antigen CAR T and combination with other regimens may reduce the relapse rate. We conducted CD22/CD19 CAR T-cells and blinatumoab combined with auto-HSCT "sandwich " strategy as consolidation therapy in patients with B-ALL. The main Purpose of this study was to observe the safety and efficacy of this new strategy.
Clinical Trial for the Safety and Efficacy of Induction Chemotherapy With Azacitidine+Venetoclax (VA) and Bridging CD19CD22 CAR-T Therapy in Adult Patients With Newly Diagnosed High-Risk and Ph-negative (Ph-) B-ALL
Clinical trial for the safety and efficacy of induction chemotherapy with VA regime and bridging CD19CD22 CAR-T therapy in adult patients with newly diagnosed high-risk and Ph- B-ALL
100 Clinical Results associated with CD19CD22 CAR-T Therapy(The First Affiliated Hospital of Soochow University)
100 Translational Medicine associated with CD19CD22 CAR-T Therapy(The First Affiliated Hospital of Soochow University)
100 Patents (Medical) associated with CD19CD22 CAR-T Therapy(The First Affiliated Hospital of Soochow University)
100 Deals associated with CD19CD22 CAR-T Therapy(The First Affiliated Hospital of Soochow University)